CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Viewpoints: Texas' indifference to health needs for the poor; Sen. Grassley says IRS is too busy to deal with health law

The state with the country's worst health care record just happens to have a governor who has been the loudest voice against national efforts to improve it. A quarter of the residents of Texas, 6.3 million people, are uninsured, by far the highest percentage in the country. ... Yet Gov. Rick Perry -; strangely puffed up as he was so often in his presidential bid -; recently told the Obama administration that he would proudly refuse a huge infusion of Medicaid money that would significantly reduce those shameful statistics and cover 1.7 million more people.

18 Jul 2012

D-ribose effective in improving QOL in energy-depleted patients with FMS/CFS

A new multicenter study published in The Open Pain Journal showed that daily consumption of the pentose carbohydrate D-ribose resulted in an average energy boost of 61 percent among patients diagnosed with Chronic Fatigue Syndrome (CFS) and fibromyalgia (FMS).

17 Jul 2012

Treatment of Schizophrenia receives notice of intention to grant a European patent

BioLineRx (NASDAQ:BLRX)(TASE:BLRX), a biopharmaceutical development company, announced today that it has received from the European Patent Office a notice of intention to grant a European patent claiming the salt of BL-1020, a first-in-class orally available treatment for schizophrenia.

9 Jul 2012

FDA approves Abbott’s Healon EndoCoat OVD device

Abbott announced today that it has expanded its Healon family of ophthalmic viscosurgical devices (OVDs) with the U.S. Food and Drug Administration approval of Healon EndoCoat OVD, a device intended for use as a surgical aid in cataract extraction and intraocular lens (IOL) implantation.

4 Jul 2012

Study illuminates key step in the journey of inflammation-producing immune cells

Like detectives seeking footprints and other clues on a television "whodunit," science can also benefit from analyzing the tracks of important players in the body's molecular landscape. Klaus Ley, M.D., a scientist at the La Jolla Institute for Allergy & Immunology, has done just that and illuminated a key step in the journey of inflammation-producing immune cells.

2 Jul 2012

Ruling on health care roils the markets

Hospital stocks surged but insurance stocks fell.

30 Jun 2012

Health system changes move forward

Press reports detail the steps that might happen next in terms of the health law's implementation as well as what the decision might mean for consumers.

30 Jun 2012

MAP Pharmaceuticals completes End-of-Review meeting with FDA for LEVADEX NDA

MAP Pharmaceuticals, Inc. today announced that the Company completed an End-of-Review meeting with the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

25 Jun 2012

North Shore-LIJ installs new imaging technology that uses lower radiation doses for CT scans

GE Healthcare today unveiled the GE Blueprint for low dose, a comprehensive program that helps healthcare providers integrate CT technologies, education and process improvements, and data analysis to reduce patient radiation dose from Computed Tomography (CT) by up to 50 percent.

22 Jun 2012

Simple exercise stress test still the most widely used medical test for coronary artery disease

Most people might assume that technology first developed in 1928 would be obsolete by now. But from air conditioned buildings to sliced bread, many inventions of that era are still essential to our lives today. That includes the exercise stress test, which is still the most widely used medical test for coronary artery disease.

15 Jun 2012

JCAD publishes results from clincal study of Tria Skin Perfecting Blue Light for acne

The Journal of Clinical and Aesthetic Dermatology (JCAD), a respected peer-reviewed dermatology publication, has, in its May 2012 issue, published the results of a single-center study of the Tria Skin Perfecting Blue Light for acne, showcasing the overall effectiveness of the device in significantly reducing the amount of acne, as well as the frequency, severity and redness of acne flares.

10 Jun 2012

Roundup: Calif. cigarette tax hike too close to call; Mass. insurance mandate not as contentious; Sept. 11 health fund cancer coverage ruling delayed

Tobacco companies poured nearly $47 million into defeating Proposition 29, a $1-a-pack tax hike on cigarettes, but the measure was narrowly leading in early returns Tuesday despite the hard-fought campaign. The tax increase would raise $810 million a year for cancer research and smoking cessation programs, and it would give California -- which currently has a lower tobacco tax than 32 other states -- the 16th-highest cigarette tax in the nation. … The vote would be a huge win for the public health groups that sponsored the measure, including the American Cancer Society.

6 Jun 2012

Prenatal Imaging Center offers new ultrasound technology with high image clarity

Prenatal Imaging Center, LLC is the only imaging center in the Kansas area to offer HDlive. HDlive is the newest ultrasound technology available and provides extraordinary image clarity. This equipment provides an even more detailed view of baby and womb.

2 Jun 2012

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.

31 May 2012

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Insmed Incorporated, a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.

24 May 2012

$Children with pelvic and thigh fractures rarely develop dangerous blood clots$

Children with pelvic and thigh fractures rarely develop dangerous blood clots

Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.

21 May 2012

$Anti-clotting drugs rarely needed in children with big-bone fractures$

CLARITY News and Research

Further Reading

Viewpoints: Texas' indifference to health needs for the poor; Sen. Grassley says IRS is too busy to deal with health law

D-ribose effective in improving QOL in energy-depleted patients with FMS/CFS

Treatment of Schizophrenia receives notice of intention to grant a European patent

FDA approves Abbott’s Healon EndoCoat OVD device

Study illuminates key step in the journey of inflammation-producing immune cells

Ruling on health care roils the markets

Health system changes move forward

MAP Pharmaceuticals completes End-of-Review meeting with FDA for LEVADEX NDA

North Shore-LIJ installs new imaging technology that uses lower radiation doses for CT scans

Simple exercise stress test still the most widely used medical test for coronary artery disease

JCAD publishes results from clincal study of Tria Skin Perfecting Blue Light for acne

Roundup: Calif. cigarette tax hike too close to call; Mass. insurance mandate not as contentious; Sept. 11 health fund cancer coverage ruling delayed

Prenatal Imaging Center offers new ultrasound technology with high image clarity

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Children with pelvic and thigh fractures rarely develop dangerous blood clots

Anti-clotting drugs rarely needed in children with big-bone fractures

Large survey of genetic variation offers insights into human diseases

More than 55% of U.S. adults lose or break their sunglasses every year

New insight into treatment patterns for people with stage two and three rectal cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News